menu
    • menu

    Company profile for Biorchestra

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BIORCHESTRA is an innovative biotech company focusing on research and development of ribonucleic acid (RNA) based therapeutics. Our goal is to change the therapeutic paradigm from treating the symptoms to providing fundamental cure of the diseases. As we are making steady progress in the clinical development, we seek global partners to collaborate in the areas of research and development (R&D) and the commercialization.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Biorchestrakorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    615 ~ 619, Unit B, 17, Techno 4-ro, Yuseong-gu, Daejeon, Republic of Korea 340...
    Telephone
    Telephone
    +82428631013
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://biorchestra.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/biorchestra-co-ltd/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biorchestra Wins Grand Prize in 2023 Merck Advance Biotech Grant Program
    Biorchestra Wins Grand Prize in 2023 Merck Advance Biotech Grant Program

    17 Jul 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biorchestra-wins-grand-prize-in-2023-merck-advance-biotech-grant-program-301878509.html

    PR NEWSWIRE
    17 Jul 2023
    Share Share
    BIORCHESTRA Invited to Present Update on Central Nervous System Lead Program
    BIORCHESTRA Invited to Present Update on Central Nervous System Lead Program

    01 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biorchestra-invited-to-present-update-on-central-nervous-system-lead-program-bmd-001-and-iv-formulated-sirna-data-at-bio2023-international-conference-301839823.html

    PR NEWSWIRE
    01 Jun 2023
    Share Share
    Biorchestra Scientific Founder, Chairman, And Ceo Joins The (Rok)
    Biorchestra Scientific Founder, Chairman, And Ceo Joins The (Rok)

    25 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biorchestra-scientific-founder-chairman-and-chief-executive-officer-joins-the-republic-of-korea-rok-official-state-visit-to-the-united-states-301805185.html

    PR NEWSWIRE
    25 Apr 2023
    Share Share
    Biorchestra Announces Significant Progress in Studies of BMD-001 Drug Program
    Biorchestra Announces Significant Progress in Studies of BMD-001 Drug Program

    24 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biorchestra-announces-significant-progress-in-studies-of-bmd-001-drug-program-301805288.html

    PR NEWSWIRE
    24 Apr 2023
    Share Share
    Biorchestra Appoints David Oxley as Chief Business Officer
    Biorchestra Appoints David Oxley as Chief Business Officer

    05 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biorchestra-expands-executive-leadership-team-with-the-appointment-of-david-oxley-as-chief-business-officer-301790667.html

    PR NEWSWIRE
    05 Apr 2023
    Share Share
    Biorchestra Pens a Pact Worth up to $861M for CNS-Targeted Polymeric Nanoparticle for Intravenous Delivery of Nucleic Acid Therapies
    Biorchestra Pens a Pact Worth up to $861M for CNS-Targeted Polymeric Nanoparticle for Intravenous Delivery of Nucleic Acid Therapies

    28 Mar 2023

    // BIOSPACE

    https://www.biospace.com/article/releases/biorchestra-pens-a-pact-worth-up-to-861m-for-central-nervous-system-cns-targeted-polymeric-nanoparticle-for-intravenous-delivery-of-nucleic-acid-therapies/

    BIOSPACE
    28 Mar 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search